<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00799916</url>
  </required_header>
  <id_info>
    <org_study_id>GEM 001</org_study_id>
    <nct_id>NCT00799916</nct_id>
  </id_info>
  <brief_title>Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis</brief_title>
  <official_title>Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Nacional de La Plata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clínica Bazterrica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanatorio Otamendi y Miroli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Agency for Scientific and Technological Promotion, Argentina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Nacional de La Plata</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid resuscitation of severe sepsis may consist of natural or artificial colloids or&#xD;
      crystalloids. There is no evidence-based support for one type of fluid over another.&#xD;
&#xD;
      The investigators hypothesis is that fluid resuscitation with Voluven® is advantageous to&#xD;
      normal saline solution to improve sublingual microcirculation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Shock is the failure of circulatory system to maintain adequate cellular perfusion. Septic&#xD;
      shock is primarily a form of distributive shock and is characterized by ineffective tissue&#xD;
      oxygen delivery and extraction associated with inappropriate peripheral vasodilation despite&#xD;
      preserved or increased cardiac output. In sepsis, a complex interaction between pathologic&#xD;
      vasodilation, relative and absolute hypovolemia, myocardial dysfunction, and altered blood&#xD;
      flow distribution occurs due to the inflammatory response to infection. Even after the&#xD;
      restoration of intravascular volume, microcirculatory abnormalities may persist and lead to&#xD;
      maldistribution of cardiac output.&#xD;
&#xD;
      Notwithstanding the complexity of its pathophysiology and treatment, to maintain adequate&#xD;
      organ perfusion is a main goal in the management of severe sepsis and septic shock. For this&#xD;
      purpose, optimization of intravascular volume and preload is the more important step. Fluid&#xD;
      challenge is a term used to describe the initial volume expansion period in which the&#xD;
      response of the patient to fluid administration is carefully evaluated. During this process,&#xD;
      large amounts of fluids may be administered over a short period of time under close&#xD;
      monitoring to evaluate the patient's response and avoid the development of pulmonary edema.&#xD;
      Fluid challenge should be given in all patients suspected of hypovolemia. Fluid resuscitation&#xD;
      may consist of natural or artificial colloids or crystalloids. There is no evidence-based&#xD;
      support for one type of fluid over another. As the volume of distribution is much larger for&#xD;
      crystalloids than for colloids, resuscitation with crystalloids requires more fluid to&#xD;
      achieve the same end points and might result in more edema. In addition, post-hoc analysis&#xD;
      and experimental studies suggest that colloids might be superior to crystalloids, in terms of&#xD;
      physiologic end-points, recruitment of the microcirculation and mortality.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sublingual microcirculation</measure>
    <time_frame>24 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gases, hemoglobin and oxygen saturations</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrolytes and lactate</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anion gap corrected to albumin</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Voluven</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Resuscitation fluid: Voluven (R)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Resuscitation fluid: Saline solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Resuscitation (Voluven)</intervention_name>
    <description>Resuscitation aimed at venous oxygen saturation higher than 70%</description>
    <arm_group_label>Voluven</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Resuscitation (Saline)</intervention_name>
    <description>Resuscitation aimed at venous oxygen saturation higher than 70%</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Severe sepsis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age of less than 18 years&#xD;
&#xD;
          -  Pregnancy, or the presence of an acute cerebral vascular event, acute coronary&#xD;
             syndrome, acute pulmonary edema, status asthmatics&#xD;
&#xD;
          -  Cardiac dysrhythmias (as a primary diagnosis), contraindication to central venous&#xD;
             catheterization, active gastrointestinal hemorrhage, seizure&#xD;
&#xD;
          -  Drug overdose, burn injury, trauma, a requirement for immediate surgery, uncured&#xD;
             cancer (during chemotherapy&#xD;
&#xD;
          -  Immunosuppression (because of organ transplantation or systemic disease),&#xD;
             do-not-resuscitate status, advanced directives restricting implementation of the&#xD;
             protocol&#xD;
&#xD;
          -  Delayed admission to ICU from emergency department (more than 4 hours), or fluid&#xD;
             resuscitation previous to ICU with more than 1,500 cc&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaldo Dubin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanatorio Otamendi y Miroli</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinica Bazterrica</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica Santa Isabel</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio Otamendi y Miroli</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <study_first_submitted>November 28, 2008</study_first_submitted>
  <study_first_submitted_qc>November 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2008</study_first_posted>
  <last_update_submitted>September 14, 2009</last_update_submitted>
  <last_update_submitted_qc>September 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Analía Pérez/Dirección de evaluación de medicamentos</name_title>
    <organization>Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT)</organization>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Fluid resuscitation</keyword>
  <keyword>Voluven</keyword>
  <keyword>Colloids</keyword>
  <keyword>Saline solution</keyword>
  <keyword>Crystalloids</keyword>
  <keyword>Sublingual microcirculation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

